No contraindication to internal jugular central venous catheter insertion in patients at increased risk of bleeding: Results from a prospective observational study in a internal medicine department

Implantation of centrally inserted central venous catheter (CICC) may be complicated by bleedings particularly in patients with severe coagulopathy or taking antithrombotic drugs. It has been shown that the application of the Italian Group for Venous Access Devices (GAVeCeLT) bundle reduces the inci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of vascular access 2024-02, p.11297298241227248-11297298241227248
Hauptverfasser: Mumoli, Nicola, Mereghetti, Marco, Capra, Riccardo, Pistoia, Matteo, Dalla Torre, Laura, Dentali, Francesco, Giarretta, Igor
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11297298241227248
container_issue
container_start_page 11297298241227248
container_title The journal of vascular access
container_volume
creator Mumoli, Nicola
Mereghetti, Marco
Capra, Riccardo
Pistoia, Matteo
Dalla Torre, Laura
Dentali, Francesco
Giarretta, Igor
description Implantation of centrally inserted central venous catheter (CICC) may be complicated by bleedings particularly in patients with severe coagulopathy or taking antithrombotic drugs. It has been shown that the application of the Italian Group for Venous Access Devices (GAVeCeLT) bundle reduces the incidence of bleeding in patients admitted to intensive care units (ICU), but its effectiveness has never been demonstrated in different contexts. In this study we evaluated the incidence of bleeding after urgent internal jugular CICC (J-CICC) implantation in patients with increased or no risk of bleeding complications when recommended preventive strategies are applied systematically. We included 185 patients admitted to Internal Medicine Units who underwent urgent J-CICC implantation from April 2016 to December 2018. The incidence of major and minor bleeding immediately after the procedure and in the following 30 days was recorded. None of the enrolled patients showed major bleeding. The incidence of minor bleedings was 2.1% (95% IC: 0.03-4.2) with two patients requiring line removal and repositioning (1.1%; 95% IC: -0.45 to 2.6). Bleeds were not correlated with age or sex, although they all occurred in female subjects. The incidence of bleeds was not increased in patients with increased risk of bleeding compared with those without (5.0% vs 1.3%;  = 0.16). The use of anti-thrombotic medications was significantly associated with increased risk of minor bleedings (  = 0.03). In this study we demonstrated that the application of the GAVeCeLT suggested bundle can minimize the number of bleeding complications even in patients hospitalized in Internal Medicine Units. Further data are needed in patients taking antithrombotic drugs who appear to be more prone to minor bleeding, however the benefit of completing the procedure appears to significantly outweigh the risk of mechanical complications.
doi_str_mv 10.1177/11297298241227248
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929129760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929129760</sourcerecordid><originalsourceid>FETCH-LOGICAL-c253t-7d38593d58d33b9f262ef30685d126621fe9cad62eb226bb51856b77f3bdad543</originalsourceid><addsrcrecordid>eNplkctu1TAQhi0Eou2BB2CDZskmJbZzMztUlYtUgYRgHfkyKS6JHWznSH1A3otJW2DBanz55p_Lz9gLXp9z3vevOReqF2oQDReiF83wiJ1yilVXS_GYzvRf7cAJO8v5pq6FannzlJ3IQdayUfUp-_Upgo2hJO2D81YXHwOUCD4UTEHPcLNdb7NOYHGHZjhiiFsGIr8jIQRmTHdZPsBK-cRl0IWuNqHO6CD5_APiBGZGdD5cv4EvmLeZsCnFBTSsKeYVbfFHhGhI73jXB1XLZXO3u7L-19FCItYHBIerTmWhgs_Yk0nPGZ8_xAP79u7y68WH6urz-48Xb68qK1pZqt7JoVXStYOT0qhJdAInWXdD67joOsEnVFY7ejVCdMa0fGg70_eTNE67tpEH9upelzr-uWEu4-KzxXnWAWkro1BC7Z7Q_g-M36OWhssJp3FNftHpduT1uLs3_uce5bx8kN8MTfk3449d8jeie5qR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929129760</pqid></control><display><type>article</type><title>No contraindication to internal jugular central venous catheter insertion in patients at increased risk of bleeding: Results from a prospective observational study in a internal medicine department</title><source>SAGE Complete A-Z List</source><creator>Mumoli, Nicola ; Mereghetti, Marco ; Capra, Riccardo ; Pistoia, Matteo ; Dalla Torre, Laura ; Dentali, Francesco ; Giarretta, Igor</creator><creatorcontrib>Mumoli, Nicola ; Mereghetti, Marco ; Capra, Riccardo ; Pistoia, Matteo ; Dalla Torre, Laura ; Dentali, Francesco ; Giarretta, Igor</creatorcontrib><description>Implantation of centrally inserted central venous catheter (CICC) may be complicated by bleedings particularly in patients with severe coagulopathy or taking antithrombotic drugs. It has been shown that the application of the Italian Group for Venous Access Devices (GAVeCeLT) bundle reduces the incidence of bleeding in patients admitted to intensive care units (ICU), but its effectiveness has never been demonstrated in different contexts. In this study we evaluated the incidence of bleeding after urgent internal jugular CICC (J-CICC) implantation in patients with increased or no risk of bleeding complications when recommended preventive strategies are applied systematically. We included 185 patients admitted to Internal Medicine Units who underwent urgent J-CICC implantation from April 2016 to December 2018. The incidence of major and minor bleeding immediately after the procedure and in the following 30 days was recorded. None of the enrolled patients showed major bleeding. The incidence of minor bleedings was 2.1% (95% IC: 0.03-4.2) with two patients requiring line removal and repositioning (1.1%; 95% IC: -0.45 to 2.6). Bleeds were not correlated with age or sex, although they all occurred in female subjects. The incidence of bleeds was not increased in patients with increased risk of bleeding compared with those without (5.0% vs 1.3%;  = 0.16). The use of anti-thrombotic medications was significantly associated with increased risk of minor bleedings (  = 0.03). In this study we demonstrated that the application of the GAVeCeLT suggested bundle can minimize the number of bleeding complications even in patients hospitalized in Internal Medicine Units. Further data are needed in patients taking antithrombotic drugs who appear to be more prone to minor bleeding, however the benefit of completing the procedure appears to significantly outweigh the risk of mechanical complications.</description><identifier>ISSN: 1129-7298</identifier><identifier>EISSN: 1724-6032</identifier><identifier>DOI: 10.1177/11297298241227248</identifier><identifier>PMID: 38303490</identifier><language>eng</language><publisher>United States</publisher><ispartof>The journal of vascular access, 2024-02, p.11297298241227248-11297298241227248</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c253t-7d38593d58d33b9f262ef30685d126621fe9cad62eb226bb51856b77f3bdad543</cites><orcidid>0000-0001-5380-0843</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38303490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mumoli, Nicola</creatorcontrib><creatorcontrib>Mereghetti, Marco</creatorcontrib><creatorcontrib>Capra, Riccardo</creatorcontrib><creatorcontrib>Pistoia, Matteo</creatorcontrib><creatorcontrib>Dalla Torre, Laura</creatorcontrib><creatorcontrib>Dentali, Francesco</creatorcontrib><creatorcontrib>Giarretta, Igor</creatorcontrib><title>No contraindication to internal jugular central venous catheter insertion in patients at increased risk of bleeding: Results from a prospective observational study in a internal medicine department</title><title>The journal of vascular access</title><addtitle>J Vasc Access</addtitle><description>Implantation of centrally inserted central venous catheter (CICC) may be complicated by bleedings particularly in patients with severe coagulopathy or taking antithrombotic drugs. It has been shown that the application of the Italian Group for Venous Access Devices (GAVeCeLT) bundle reduces the incidence of bleeding in patients admitted to intensive care units (ICU), but its effectiveness has never been demonstrated in different contexts. In this study we evaluated the incidence of bleeding after urgent internal jugular CICC (J-CICC) implantation in patients with increased or no risk of bleeding complications when recommended preventive strategies are applied systematically. We included 185 patients admitted to Internal Medicine Units who underwent urgent J-CICC implantation from April 2016 to December 2018. The incidence of major and minor bleeding immediately after the procedure and in the following 30 days was recorded. None of the enrolled patients showed major bleeding. The incidence of minor bleedings was 2.1% (95% IC: 0.03-4.2) with two patients requiring line removal and repositioning (1.1%; 95% IC: -0.45 to 2.6). Bleeds were not correlated with age or sex, although they all occurred in female subjects. The incidence of bleeds was not increased in patients with increased risk of bleeding compared with those without (5.0% vs 1.3%;  = 0.16). The use of anti-thrombotic medications was significantly associated with increased risk of minor bleedings (  = 0.03). In this study we demonstrated that the application of the GAVeCeLT suggested bundle can minimize the number of bleeding complications even in patients hospitalized in Internal Medicine Units. Further data are needed in patients taking antithrombotic drugs who appear to be more prone to minor bleeding, however the benefit of completing the procedure appears to significantly outweigh the risk of mechanical complications.</description><issn>1129-7298</issn><issn>1724-6032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNplkctu1TAQhi0Eou2BB2CDZskmJbZzMztUlYtUgYRgHfkyKS6JHWznSH1A3otJW2DBanz55p_Lz9gLXp9z3vevOReqF2oQDReiF83wiJ1yilVXS_GYzvRf7cAJO8v5pq6FannzlJ3IQdayUfUp-_Upgo2hJO2D81YXHwOUCD4UTEHPcLNdb7NOYHGHZjhiiFsGIr8jIQRmTHdZPsBK-cRl0IWuNqHO6CD5_APiBGZGdD5cv4EvmLeZsCnFBTSsKeYVbfFHhGhI73jXB1XLZXO3u7L-19FCItYHBIerTmWhgs_Yk0nPGZ8_xAP79u7y68WH6urz-48Xb68qK1pZqt7JoVXStYOT0qhJdAInWXdD67joOsEnVFY7ejVCdMa0fGg70_eTNE67tpEH9upelzr-uWEu4-KzxXnWAWkro1BC7Z7Q_g-M36OWhssJp3FNftHpduT1uLs3_uce5bx8kN8MTfk3449d8jeie5qR</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Mumoli, Nicola</creator><creator>Mereghetti, Marco</creator><creator>Capra, Riccardo</creator><creator>Pistoia, Matteo</creator><creator>Dalla Torre, Laura</creator><creator>Dentali, Francesco</creator><creator>Giarretta, Igor</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5380-0843</orcidid></search><sort><creationdate>20240201</creationdate><title>No contraindication to internal jugular central venous catheter insertion in patients at increased risk of bleeding: Results from a prospective observational study in a internal medicine department</title><author>Mumoli, Nicola ; Mereghetti, Marco ; Capra, Riccardo ; Pistoia, Matteo ; Dalla Torre, Laura ; Dentali, Francesco ; Giarretta, Igor</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c253t-7d38593d58d33b9f262ef30685d126621fe9cad62eb226bb51856b77f3bdad543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mumoli, Nicola</creatorcontrib><creatorcontrib>Mereghetti, Marco</creatorcontrib><creatorcontrib>Capra, Riccardo</creatorcontrib><creatorcontrib>Pistoia, Matteo</creatorcontrib><creatorcontrib>Dalla Torre, Laura</creatorcontrib><creatorcontrib>Dentali, Francesco</creatorcontrib><creatorcontrib>Giarretta, Igor</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of vascular access</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mumoli, Nicola</au><au>Mereghetti, Marco</au><au>Capra, Riccardo</au><au>Pistoia, Matteo</au><au>Dalla Torre, Laura</au><au>Dentali, Francesco</au><au>Giarretta, Igor</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No contraindication to internal jugular central venous catheter insertion in patients at increased risk of bleeding: Results from a prospective observational study in a internal medicine department</atitle><jtitle>The journal of vascular access</jtitle><addtitle>J Vasc Access</addtitle><date>2024-02-01</date><risdate>2024</risdate><spage>11297298241227248</spage><epage>11297298241227248</epage><pages>11297298241227248-11297298241227248</pages><issn>1129-7298</issn><eissn>1724-6032</eissn><abstract>Implantation of centrally inserted central venous catheter (CICC) may be complicated by bleedings particularly in patients with severe coagulopathy or taking antithrombotic drugs. It has been shown that the application of the Italian Group for Venous Access Devices (GAVeCeLT) bundle reduces the incidence of bleeding in patients admitted to intensive care units (ICU), but its effectiveness has never been demonstrated in different contexts. In this study we evaluated the incidence of bleeding after urgent internal jugular CICC (J-CICC) implantation in patients with increased or no risk of bleeding complications when recommended preventive strategies are applied systematically. We included 185 patients admitted to Internal Medicine Units who underwent urgent J-CICC implantation from April 2016 to December 2018. The incidence of major and minor bleeding immediately after the procedure and in the following 30 days was recorded. None of the enrolled patients showed major bleeding. The incidence of minor bleedings was 2.1% (95% IC: 0.03-4.2) with two patients requiring line removal and repositioning (1.1%; 95% IC: -0.45 to 2.6). Bleeds were not correlated with age or sex, although they all occurred in female subjects. The incidence of bleeds was not increased in patients with increased risk of bleeding compared with those without (5.0% vs 1.3%;  = 0.16). The use of anti-thrombotic medications was significantly associated with increased risk of minor bleedings (  = 0.03). In this study we demonstrated that the application of the GAVeCeLT suggested bundle can minimize the number of bleeding complications even in patients hospitalized in Internal Medicine Units. Further data are needed in patients taking antithrombotic drugs who appear to be more prone to minor bleeding, however the benefit of completing the procedure appears to significantly outweigh the risk of mechanical complications.</abstract><cop>United States</cop><pmid>38303490</pmid><doi>10.1177/11297298241227248</doi><orcidid>https://orcid.org/0000-0001-5380-0843</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1129-7298
ispartof The journal of vascular access, 2024-02, p.11297298241227248-11297298241227248
issn 1129-7298
1724-6032
language eng
recordid cdi_proquest_miscellaneous_2929129760
source SAGE Complete A-Z List
title No contraindication to internal jugular central venous catheter insertion in patients at increased risk of bleeding: Results from a prospective observational study in a internal medicine department
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A48%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20contraindication%20to%20internal%20jugular%20central%20venous%20catheter%20insertion%20in%20patients%20at%20increased%20risk%20of%20bleeding:%20Results%20from%20a%20prospective%20observational%20study%20in%20a%20internal%20medicine%20department&rft.jtitle=The%20journal%20of%20vascular%20access&rft.au=Mumoli,%20Nicola&rft.date=2024-02-01&rft.spage=11297298241227248&rft.epage=11297298241227248&rft.pages=11297298241227248-11297298241227248&rft.issn=1129-7298&rft.eissn=1724-6032&rft_id=info:doi/10.1177/11297298241227248&rft_dat=%3Cproquest_cross%3E2929129760%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2929129760&rft_id=info:pmid/38303490&rfr_iscdi=true